Last Updated : July 31, 2006
Details
FilesGeneric Name:
Sorafenib tablets
Project Status:
Complete
Therapeutic Area:
Cancer, Renal cell carcinoma
Manufacturer:
Bayer Inc.
Brand Name:
Nexavar
Project Line:
Reimbursement Review
Project Number:
SR0071-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Cancer, Renal cell carcinoma
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : July 31, 2006